Reviva Pharmaceuticals Holdings SG&A Expense (Quarterly) Insights

Reviva Pharmaceuticals Holdings Inc (RVPH)

1.44 -0.02 (-1.37%) USD | NASDAQ | Jun 17, 16:00

1.44 0.00 (0.00%) After-Hours: 16:42

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	2.138M
December 31, 2023	1.512M
September 30, 2023	1.992M
June 30, 2023	3.079M
March 31, 2023	1.501M
December 31, 2022	1.476M
September 30, 2022	1.257M
June 30, 2022	1.005M
March 31, 2022	1.620M

Date	Value
December 31, 2021	1.302M
September 30, 2021	1.054M
June 30, 2021	1.416M
March 31, 2021	1.481M
December 31, 2020	0.5267M
November 30, 2020
September 30, 2020	0.5113M
June 30, 2020	0.7409M
March 31, 2020	0.347M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.347M

Minimum

Mar 2020

3.079M

Maximum

Jun 2023

1.350M

Average

1.416M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks